查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1985602

人工授精市场：依动物种类、授精方法、精液来源及最终使用者划分－2026-2032年全球市场预测

Artificial Insemination Market by Animal Type, Insemination Technique, Source of Sperm, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，人工授精市场价值将达到 37.1 亿美元，到 2026 年将成长至 40.2 亿美元，到 2032 年将达到 68.4 亿美元，复合年增长率为 9.13%。

主要市场统计数据
基准年 2025 37.1亿美元
预计年份：2026年 40.2亿美元
预测年份 2032 68.4亿美元
复合年增长率 (%) 9.13%

畜牧业人工授精技术的全面实施：聚焦创新、关键挑战及在生产力和疾病管理方面的策略价值

人工授精已从一项小众的兽医服务发展成为现代畜牧系统中提高生产力、改良遗传品种和保障生物安全的战略工具。如今，从业者和商业人士都将繁殖技术视为畜群管理不可或缺的一部分，其影响范围涵盖农场层面的生产力、国家育种计划以及国际遗传资源贸易。精液处理、冷冻保存和妊娠诊断技术的进步拓展了生产者可获得的服务范围，但管理体制和动物健康通讯协定仍在不断影响着相关实践的开展方式。

基因组学、精准育种工具、数位受孕分析以及对永续性的关注，正在重塑人工授精产业，带来变革性的转变。

在基因组学、精准育种和数位分析等突破性进展的推动下，人工授精领域正经历着一场变革。基因组选择缩短了遗传改良週期，实现了更精准的牛选择，并加速了优良性状的传播。同时，精液性别分选和冷冻保存技术的进步正在改变生产者规划育种週期和管理牛群组成的方式。除了这些技术进步之外，利用育种模型、机器学习和即时监测的决策支援工具也使得人工授精时机的最佳化和结果预测的可靠性显着提高。

2025 年美国关税变化对人工授精供应链、跨境遗传资源贸易和生殖经济的累积影响分析。

美国2025年实施的关税调整将对遗传资源贸易、设备采购和服务经济产生累积影响，但不会改变生殖技术的基本需求驱动因素。关税带来的成本压力可能会推高进口精液、冷冻保存设备和专用耗材的到货价格，从而影响育种公司和服务供应商的筹资策略。为此，供应链将进行重组。各公司将重新审视其供应商组合，加快国内采购产品的认证，并重新思考其库存策略，以应对突如其来的成本衝击。

透过细分洞察动物物种和品种层级类别如何影响人工授精实践、服务提供模式以及跨物种的价值。

市场区隔有助于深入了解不同动物物种和品种等级的需求和服务差异，以及商业策略为何必须根据物种特有的生物学特性和生产者的经济状况定制。本研究涵盖牛、家禽、绵羊/山羊和牛，每种动物都有其独特的运行节奏和育种通讯协定，这些都会影响人工授精服务的设计。对于牛，本研究区分了肉牛和乳牛养殖，并认识到产量目标、发情週期和每头犊牛的价值会影响其优先事项。本研究也检视了牛的子类别，例如安格斯牛和赫里福德牛，其中性状选择和市场导向决定了牛的使用和遗传育种计划。牛的育种决策受到高价值荷斯坦牛和泽西牛品种遗传特性的影响，这些品种推动了对生育力监测和精液品管的投资。

对美洲、欧洲、中东和非洲以及亚太地区的人工授精采用、监管和供应链韧性进行区域分析。

区域环境对人工授精服务的采用模式、监管方式及商业生态係有显着影响。在美洲，成熟的商业性育种计画和一体化的供应链为先进基因的推广提供了支持，但生产者在生物安全标准和物流方面面临区域差异，这影响了服务的提供。欧洲、中东和非洲地区的管理体制和市场成熟度呈现多元化的特征。严格的动物健康框架和可追溯性要求与新兴市场并存，在这些新兴市场中，能力建设和知识转移正在推动早期成长。在亚太地区，高密度生产区域以及精准畜牧技术的快速应用，催生了对可扩展解决方案和区域性育种策略的需求。

从企业层面深入了解育种者、遗传资源提供者和生殖技术领导者之间的竞争定位、伙伴关係和专业化程度。

在公司层面，趋势揭示了技术能力、服务产品和策略伙伴关係之间的相互作用，这些因素共同塑造了人工授精生态系统中的竞争优势。领先的遗传资源供应商和专业服务公司正在投资垂直整合能力，将牛选择、精液处理和分销网络相结合，以确保产品品质并缩短交付时间。与生物技术公司、兽医服务机构和精密农业软体供应商的策略合作，正在加速基因组和数据驱动的进步向商业性产品和服务的快速转化。

为领导者提供切实可行的建议，以加快采用速度、增强供应韧性、优化遗传资源管道，并使业务营运与数位化和永续发展目标保持一致。

希望在不断发展的人工授精市场中获利的企业领导者应实施一系列重点营运措施，以平衡短期韧性和中期成长。首先，优先考虑供应商关係多元化，并探索区域精液加工和本地伙伴关係，以降低跨境中断和关税影响的风险。其次，加速采用成熟的生殖分析和监测工具，以提高受孕率，并提供可衡量的服务水准指标，从而证明提供加值服务的合理性。第三，投资提升人力资源能力，透过规范人工授精负责人和兽医技术人员的培训，并建构可扩展、可复製的服务模式，同时确保服务品质。

调查方法结合了与专家的初步访谈、实地检验、供应链映射和混合方法分析，得出了可操作且可靠的见解。

本分析所依据的研究整合了多种证据来源，以确保其稳健性和实用性。研究方法首先是对生殖技术、冷冻保存和基因组学领域的科学文献进行广泛回顾，随后对兽医、育种专案经理、物流专家和设备供应商进行结构化访谈。实地检验包括对典型生产基地进行现场考察和营运评估，以观察服务提供模式、精液处理流程以及农民的采纳行为。此外，研究还透过梳理法律规范、进出口要求和已发布的技术标准，补充了原始资讯。

总结了相关人员在调整育种计划、伙伴关係和投资方面的策略意义、风险因素和机会途径。

总之，人工授精领域正处于一个转折点，技术创新、政策趋势和不断变化的生产者期望交织在一起，迫使服务模式和竞争定位进行重组。遗传学和数位化育种管理工具的进步为提高生产力和改善动物健康提供了清晰的路径，而区域和贸易因素则要求采取灵活的供应链策略。将基因组分析的精准性与稳健的营运管理、透明的可追溯性和有针对性的人才培养相结合的相关人员，将更有利于创造价值并降低风险。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：人工授精市场：依动物类型划分

  • 牛
    • 牛
      • 安格斯
      • 赫里福德
    • 乳製品
      • 荷斯坦
      • 球衣
  • 家禽
    • 肉鸡
    • 取卵
  • 绵羊/山羊
    • 山羊
    • 羊
  • 猪
    • 商业的
    • 本地物种

第九章 依授精方式分類的人工授精市场

  • 子宫颈内人工授精
  • 子宫内人工授精
  • 输卵管内人工授精

第十章：以精子供应来源分類的人工授精市场

  • 捐精
  • 伴侣的精子

第十一章 人工授精市场：依最终用户划分

  • 不孕症治疗诊所
  • 医院
  • 居家照护

第十二章：人工授精市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章：人工授精市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 人工授精市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国人工授精市场

第十六章 中国人工授精市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Carl Zeiss AG
  • Cook Medical Inc.
  • CooperSurgical Inc.
  • Corning incorporated
  • Esco micro pte. Ltd.
  • Ferring BV
  • FertiPro NV
  • Genea Biomedx Pty Ltd.
  • Hamilton Thorne, Inc.
  • INVO Bioscience, Inc.
  • IVFtech ApS
  • Kitazato Corporation
  • Laboratoire CCD
  • Meiji Techno Co., Ltd.
  • Merck KGaA
  • Nidacon International AB
  • Nikon Corporation
  • Olympus Corporation
  • Thermo Fisher Scientific Inc.
  • Vitrolife AB
Product Code: MRR-A37FCEE11759

The Artificial Insemination Market was valued at USD 3.71 billion in 2025 and is projected to grow to USD 4.02 billion in 2026, with a CAGR of 9.13%, reaching USD 6.84 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.71 billion
Estimated Year [2026] USD 4.02 billion
Forecast Year [2032] USD 6.84 billion
CAGR (%) 9.13%

Comprehensive introduction to artificial insemination in livestock highlighting innovations, key challenges and strategic value for productivity, disease control

Artificial insemination has evolved from a niche veterinary service into a strategic lever for productivity, genetic improvement and biosecurity across modern livestock systems. Practitioners and commercial operators now view reproductive technologies as an integral part of herd and flock management, with implications that extend from farm-level productivity to national breeding programs and international genetics trade. Advances in semen processing, cryopreservation, and fertility diagnostics have expanded the scope of services available to producers, while regulatory regimes and animal health protocols continue to shape operational practices.

Transitioning from historical practices, the sector increasingly integrates veterinary sciences, genetics, and digital monitoring to optimize reproductive outcomes. Veterinary professionals, breeding cooperatives and private genetics companies collaborate to deliver tailored programs aimed at improving conception rates, reducing disease transmission and accelerating genetic gain. At the same time, producers demand demonstrable returns on reproductive investments, prompting service providers to refine pricing, training and performance measurement. As stakeholders navigate this landscape, clarity around technology adoption pathways, compliance obligations and value realization becomes essential for both short-term operational decisions and longer-term strategic planning.

Transformative shifts reshaping artificial insemination led by genomics, precision breeding tools, digital fertility analytics and sustainability priorities

The landscape of artificial insemination is undergoing transformative shifts driven by breakthroughs in genomics, precision breeding and digital analytics. Genomic selection has shortened the cycle for genetic improvement, enabling more accurate sire selection and accelerating the dissemination of desirable traits. Concurrently, sex-sorted semen and enhancements in cryopreservation chemistry are changing how producers plan breeding cycles and manage herd composition. These technical advances are complemented by decision-support tools that apply fertility modeling, machine learning and real-time monitoring to optimize insemination timing and predict outcomes with greater reliability.

Beyond the laboratory, structural changes in service delivery are emerging. Decentralized semen distribution, mobile insemination units and increased outsourcing of reproductive services are reshaping the commercial model. These shifts respond to producer preferences for on-demand services and turnkey solutions that reduce labor burdens while maintaining biosecurity standards. Sustainability has also become a decisive factor, with stakeholders assessing carbon intensity and resource efficiency alongside genetic performance. As the sector converges around these technological and operational trends, businesses that combine validated reproductive science with robust digital tools and service models will hold a competitive advantage in meeting evolving producer expectations.

Cumulative impact analysis of United States tariff changes in 2025 on artificial insemination supply chains, cross-border genetics trade and breeding economics

The introduction of tariff adjustments in the United States during 2025 has a cumulative effect that reverberates through genetics trade, equipment sourcing and service economics without altering the underlying demand drivers for reproductive technologies. Tariff-induced cost pressures tend to raise the landed price of imported semen, cryogenic equipment and specialized consumables, which in turn affects procurement strategies among breeding companies and service providers. In response, supply chains reconfigure: firms review supplier portfolios, accelerate qualification of domestic inputs and reconsider inventory strategies to buffer against episodic cost shocks.

Policy shifts also influence trade flows for elite genetics. When cross-border movement of germplasm becomes more expensive, stakeholders may prioritize domestic sire programs or intensify collaboration with regional genetic suppliers to preserve access to desired traits. At the same time, tariff dynamics can spur investment in local processing capacity-such as onshore semen packaging and cryopreservation facilities-if the economics support it. Finally, regulatory and compliance frictions tied to trade policy amplify the need for clear documentation and traceability, prompting firms to invest in logistics, certification workflows and risk management measures that reduce exposure to tariff volatility and ensure continuity of breeding programs.

Segmentation insights into how animal type and breed-level categories shape artificial insemination practices, service delivery models and value across species

Segmentation provides a lens to understand how demand and service delivery vary across animal types and breed hierarchies, and why commercial strategies must be tailored to species-specific biology and producer economics. The market is studied across cattle, poultry, sheep and goats, and swine, with each animal type exhibiting distinct operational rhythms and reproductive protocols that influence the design of insemination services. Within cattle, the study differentiates beef and dairy operations, recognizing that production objectives, cycle cadence and value per offspring shape priorities. Beef subcategories examined include Angus and Hereford, where trait selection and market orientation determine sire utilization and genetic programs. Dairy breeding decisions hinge on high-value Holstein and Jersey genetics, which drive investments in fertility monitoring and semen quality controls.

Poultry is evaluated through broiler and layer systems, where integration with hatcheries and large-scale incubation changes the service architecture for reproductive inputs. Sheep and goats are analyzed through discrete goat and sheep programs, each with specific flock management patterns, while swine segmentation contrasts commercial and indigenous populations, exposing divergent needs for genetic improvement versus conservation. Collectively, these layers of segmentation reveal how breed-level differentiation and production system design drive product development, pricing strategies and extension services for insemination providers seeking to serve diverse client needs.

Regional insights on adoption, regulation and supply chain resilience in artificial insemination across the Americas, Europe, Middle East & Africa, and Asia-Pacific

Regional context strongly conditions adoption patterns, regulatory approaches and the shape of commercial ecosystems for insemination services. In the Americas, established commercial breeding programs and integrated supply chains support advanced genetics dissemination, yet producers face regional variance in biosecurity standards and logistics that alter service delivery. Europe, Middle East & Africa presents a mosaic of regulatory regimes and market maturity; stringent animal health frameworks and traceability expectations coexist with emerging markets where capacity building and knowledge transfer drive early-stage growth. Asia-Pacific combines high-density production zones with rapid adoption of precision livestock technologies, creating demand for scalable solutions and region-specific breeding strategies.

As a result, firms must align investment and operational models to regional realities. In mature markets, emphasis shifts toward service differentiation, data-driven fertility optimization and premium genetics, while capacity building, localized training and infrastructure support are more relevant in developing regions. Cross-border collaboration, regional hubs for semen processing and standardized compliance workflows can reduce friction and enable faster technology diffusion. Ultimately, regional nuances inform both go-to-market planning and the prioritization of local partnerships that facilitate scalable, compliant and cost-effective service rollout.

Company-level insights into competitive positioning, partnerships and specialization among breeders, genetics providers and reproductive technology leaders

Company-level dynamics reveal the interplay between technology capability, service reach and strategic partnerships that shape competitive advantage in the insemination ecosystem. Leading genetics providers and specialized service companies invest in vertically integrated capabilities-combining sire selection, semen processing and distribution networks-to ensure product quality and shorten delivery timelines. Strategic alliances with biotechnology firms, veterinary service groups and precision agriculture software vendors accelerate the translation of genomic and data-driven advances into commercially viable offerings.

Smaller, agile enterprises differentiate through niche specialization: focused breed programs, regionally optimized logistics or bundled on-farm services that include training and performance guarantees. Collaboration between established breeders and emerging technology providers also yields hybrid models that leverage scale while introducing innovation. Across the board, companies that pair robust quality assurance processes with transparent traceability and demonstrable service outcomes create trust with producers and command preferential engagement. Investment priorities among firms commonly center on cryopreservation technology, data platforms for fertility analytics and workforce training to ensure consistent execution at the farm level.

Practical recommendations for leaders to accelerate adoption, fortify supply resilience, optimize genetics pipelines and align operations with digital and sustainability goals

Leaders seeking to capture opportunity in the evolving insemination market should pursue a set of focused, operational steps that balance immediate resilience with medium-term growth. First, prioritize diversification of supplier relationships and consider regional processing or localized partnerships to reduce exposure to cross-border disruptions and tariff sensitivity. Second, accelerate adoption of proven fertility analytics and monitoring tools to improve conception outcomes and provide measurable service-level metrics that justify premium offerings. Third, invest in workforce capability by standardizing training for inseminators and veterinary technicians, creating a reproducible service model that scales without sacrificing quality.

In parallel, companies should develop clear sustainability narratives linked to breeding outcomes, resource efficiency and animal welfare to meet buyer expectations and support market differentiation. Engage proactively with regulators to shape practical compliance pathways that facilitate trade while protecting animal health. Finally, explore modular commercial models-such as subscription services, performance-linked contracts or bundled genetics and advisory packages-that align producer incentives with long-term genetic improvement and generate recurring revenue streams for providers.

Research methodology combining primary expert interviews, field validation, supply chain mapping and mixed-method analysis to produce actionable and credible insights

The research underpinning this analysis combined multiple evidence streams to ensure robustness and practical relevance. The approach began with an extensive review of scientific literature on reproductive technologies, cryopreservation and genomics, followed by structured interviews with veterinarians, breeding program managers, logistics specialists and equipment suppliers. Field validation included site visits and operational assessments to observe service delivery models, semen handling protocols and farmer adoption behaviors in representative production settings. Secondary sources supplemented primary inputs by mapping regulatory frameworks, import/export requirements and published technical standards.

Methodologically, the study applied mixed-method synthesis: qualitative insights from expert interviews contextualized quantitative indicators derived from supply chain observation and transactional patterns. Scenarios were developed to test sensitivity to policy shifts and supply disruptions, and findings were triangulated with practitioner feedback to refine recommendations. Throughout, the research emphasized transparency of assumptions and traceability of data to support reproducibility and enable tailored follow-up analyses for specific species or regions.

Conclusion summarizing strategic implications, risk considerations and opportunity pathways for stakeholders adapting breeding programs, partnerships and investments

In conclusion, the artificial insemination sector stands at an inflection point where technological innovation, policy dynamics and evolving producer expectations converge to reshape service models and competitive positioning. Genetic advances and digital fertility tools offer clear pathways to enhanced productivity and improved animal health, while regional and trade considerations require agile supply chain strategies. Stakeholders who integrate genomic precision with robust operational controls, transparent traceability and targeted workforce development will be best positioned to capture value and mitigate risk.

The cumulative lessons emphasize the need for pragmatic investment decisions that prioritize validated performance outcomes, regional alignment and sustainable practices. By combining strategic supplier diversification, focused technology adoption and collaborative regulatory engagement, organizations can translate the sector's technical progress into durable commercial advantage and meaningful improvements in livestock production outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Artificial Insemination Market, by Animal Type

  • 8.1. Cattle
    • 8.1.1. Beef
      • 8.1.1.1. Angus
      • 8.1.1.2. Hereford
    • 8.1.2. Dairy
      • 8.1.2.1. Holstein
      • 8.1.2.2. Jersey
  • 8.2. Poultry
    • 8.2.1. Broiler
    • 8.2.2. Layer
  • 8.3. Sheep & Goats
    • 8.3.1. Goats
    • 8.3.2. Sheep
  • 8.4. Swine
    • 8.4.1. Commercial
    • 8.4.2. Indigenous

9. Artificial Insemination Market, by Insemination Technique

  • 9.1. Intracervical Insemination
  • 9.2. Intrauterine Insemination
  • 9.3. Intratubal Insemination

10. Artificial Insemination Market, by Source of Sperm

  • 10.1. Donor Sperm
  • 10.2. Partner Sperm

11. Artificial Insemination Market, by End User

  • 11.1. Fertility Clinics
  • 11.2. Hospitals
  • 11.3. Home-care

12. Artificial Insemination Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Artificial Insemination Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Artificial Insemination Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Artificial Insemination Market

16. China Artificial Insemination Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Carl Zeiss AG
  • 17.6. Cook Medical Inc.
  • 17.7. CooperSurgical Inc.
  • 17.8. Corning incorporated
  • 17.9. Esco micro pte. Ltd.
  • 17.10. Ferring B.V.
  • 17.11. FertiPro N.V.
  • 17.12. Genea Biomedx Pty Ltd.
  • 17.13. Hamilton Thorne, Inc.
  • 17.14. INVO Bioscience, Inc.
  • 17.15. IVFtech ApS
  • 17.16. Kitazato Corporation
  • 17.17. Laboratoire CCD
  • 17.18. Meiji Techno Co., Ltd.
  • 17.19. Merck KGaA
  • 17.20. Nidacon International AB
  • 17.21. Nikon Corporation
  • 17.22. Olympus Corporation
  • 17.23. Thermo Fisher Scientific Inc.
  • 17.24. Vitrolife AB

LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ARTIFICIAL INSEMINATION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ARTIFICIAL INSEMINATION MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY SOURCE OF SPERM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ARTIFICIAL INSEMINATION MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY ANGUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY ANGUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY ANGUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY HEREFORD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY HEREFORD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY HEREFORD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY HOLSTEIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY HOLSTEIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY HOLSTEIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY JERSEY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY JERSEY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY JERSEY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY BROILER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY BROILER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY BROILER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY LAYER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY LAYER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY LAYER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY GOATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY GOATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY GOATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY COMMERCIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY COMMERCIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INDIGENOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INDIGENOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INDIGENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INTRACERVICAL INSEMINATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INTRACERVICAL INSEMINATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INTRACERVICAL INSEMINATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INTRATUBAL INSEMINATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INTRATUBAL INSEMINATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY INTRATUBAL INSEMINATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY SOURCE OF SPERM, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR SPERM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR SPERM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY DONOR SPERM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY PARTNER SPERM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY PARTNER SPERM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY PARTNER SPERM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY FERTILITY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY FERTILITY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY HOME-CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY HOME-CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY HOME-CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY SOURCE OF SPERM, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY SOURCE OF SPERM, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY SOURCE OF SPERM, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY SOURCE OF SPERM, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE ARTIFICIAL INSEMINATION MARKET SIZE, BY SOURCE OF SPERM, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST ARTIFICIAL INSEMINATION MARKET SIZE, BY SOURCE OF SPERM, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY SOURCE OF SPERM, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY SOURCE OF SPERM, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN ARTIFICIAL INSEMINATION MARKET SIZE, BY SOURCE OF SPERM, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. GCC ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. GCC ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. GCC ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 188. GCC ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, 2018-2032 (USD MILLION)
  • TABLE 189. GCC ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, 2018-2032 (USD MILLION)
  • TABLE 190. GCC ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 191. GCC ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 192. GCC ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 193. GCC ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 194. GCC ARTIFICIAL INSEMINATION MARKET SIZE, BY SOURCE OF SPERM, 2018-2032 (USD MILLION)
  • TABLE 195. GCC ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION ARTIFICIAL INSEMINATION MARKET SIZE, BY SOURCE OF SPERM, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS ARTIFICIAL INSEMINATION MARKET SIZE, BY SOURCE OF SPERM, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. G7 ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. G7 ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. G7 ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 221. G7 ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, 2018-2032 (USD MILLION)
  • TABLE 222. G7 ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, 2018-2032 (USD MILLION)
  • TABLE 223. G7 ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 224. G7 ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 225. G7 ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 226. G7 ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 227. G7 ARTIFICIAL INSEMINATION MARKET SIZE, BY SOURCE OF SPERM, 2018-2032 (USD MILLION)
  • TABLE 228. G7 ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. NATO ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 230. NATO ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. NATO ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 232. NATO ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, 2018-2032 (USD MILLION)
  • TABLE 233. NATO ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, 2018-2032 (USD MILLION)
  • TABLE 234. NATO ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 235. NATO ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 236. NATO ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 237. NATO ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 238. NATO ARTIFICIAL INSEMINATION MARKET SIZE, BY SOURCE OF SPERM, 2018-2032 (USD MILLION)
  • TABLE 239. NATO ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. GLOBAL ARTIFICIAL INSEMINATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY SOURCE OF SPERM, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA ARTIFICIAL INSEMINATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA ARTIFICIAL INSEMINATION MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA ARTIFICIAL INSEMINATION MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA ARTIFICIAL INSEMINATION MARKET SIZE, BY BEEF, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA ARTIFICIAL INSEMINATION MARKET SIZE, BY DAIRY, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA ARTIFICIAL INSEMINATION MARKET SIZE, BY POULTRY, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA ARTIFICIAL INSEMINATION MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA ARTIFICIAL INSEMINATION MARKET SIZE, BY SWINE, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA ARTIFICIAL INSEMINATION MARKET SIZE, BY INSEMINATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA ARTIFICIAL INSEMINATION MARKET SIZE, BY SOURCE OF SPERM, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA ARTIFICIAL INSEMINATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)